These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22185672)
1. Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Carlsson AM; Ngasala BE; Dahlström S; Membi C; Veiga IM; Rombo L; Abdulla S; Premji Z; Gil JP; Björkman A; Mårtensson A Malar J; 2011 Dec; 10():380. PubMed ID: 22185672 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD Malar J; 2009 May; 8():107. PubMed ID: 19454000 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India. Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665 [TBL] [Abstract][Full Text] [Related]
4. Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers. Oyebola KM; Ligali FC; Owoloye AJ; Aina OO; Alo YM; Erinwusi B; Olufemi MJ; Salako BL Malar J; 2024 Aug; 23(1):261. PubMed ID: 39210367 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study. Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S Malar J; 2012 Dec; 11():434. PubMed ID: 23272998 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624 [TBL] [Abstract][Full Text] [Related]
7. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial. Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897 [TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Mwingira F; Nkwengulila G; Schoepflin S; Sumari D; Beck HP; Snounou G; Felger I; Olliaro P; Mugittu K Malar J; 2011 Apr; 10():79. PubMed ID: 21470428 [TBL] [Abstract][Full Text] [Related]
9. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA; Obonyo CO; Akhwale WS; Ogutu BR Malar J; 2008 Dec; 7():262. PubMed ID: 19102746 [TBL] [Abstract][Full Text] [Related]
10. A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Toure OA; Penali LK; Yapi JD; Ako BA; Toure W; Djerea K; Gomez GO; Makaila O Malar J; 2009 Jul; 8():148. PubMed ID: 19575797 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia. Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA Malar J; 2014 Nov; 13():430. PubMed ID: 25403945 [TBL] [Abstract][Full Text] [Related]
12. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. Martensson A; Ngasala B; Ursing J; Isabel Veiga M; Wiklund L; Membi C; Montgomery SM; Premji Z; Farnert A; Bjorkman A J Infect Dis; 2007 Feb; 195(4):597-601. PubMed ID: 17230421 [TBL] [Abstract][Full Text] [Related]
13. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial. Sagara I; Rulisa S; Mbacham W; Adam I; Sissoko K; Maiga H; Traore OB; Dara N; Dicko YT; Dicko A; Djimdé A; Jansen FH; Doumbo OK Malar J; 2009 Apr; 8():63. PubMed ID: 19366448 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013. Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P Malar J; 2016 Jun; 15():331. PubMed ID: 27334876 [TBL] [Abstract][Full Text] [Related]
16. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
17. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania. Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A Malar J; 2013 Mar; 12():103. PubMed ID: 23506218 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia. Gosi P; Lanteri CA; Tyner SD; Se Y; Lon C; Spring M; Char M; Sea D; Sriwichai S; Surasri S; Wongarunkochakorn S; Pidtana K; Walsh DS; Fukuda MM; Manning J; Saunders DL; Bethell D Malar J; 2013 Nov; 12():403. PubMed ID: 24206588 [TBL] [Abstract][Full Text] [Related]
19. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series. Sondén K; Wyss K; Jovel I; Vieira da Silva A; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Färnert A Clin Infect Dis; 2017 Jan; 64(2):199-206. PubMed ID: 27986683 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Bergqvist Y; Gil JP; Premji Z; Mårtensson A Malar J; 2011 Mar; 10():64. PubMed ID: 21410954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]